Stock MAIA MAIA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MAIA Biotechnology, Inc.

Equities

MAIA

US5526411021

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
4.11 USD +9.89% Intraday chart for MAIA Biotechnology, Inc. +13.54% +251.28%
May. 21 MAIA Biotechnology, Inc. announced a financing transaction CI
Apr. 26 Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
AQ
MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024
AQ
MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2024 ANNUAL MEETING
AQ
MAIA Biotechnology to Present at the BIO International Convention 2024
BU
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
BU
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
BU
MAIA Biotechnology Announces $1.00 Million Private Placement
BU
MAIA BIOTECHNOLOGY TO PRESENT AT TWO INVESTOR CONFERENCES IN APRIL 2024
AQ
MAIA Biotechnology to Present at Two Investor Conferences in April 2024
BU
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
BU
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
BU
MAIA Biotechnology Announces $1.33 Million Private Placement
BU
MAIA BIOTECHNOLOGY ANNOUNCES SHARE PURCHASE BY DIRECTOR STAN SMITH, PHD IN A $2.9 MILLION PRIVATE PLACEMENT
AQ
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
BU
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
BU
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
BU
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
BU
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients
BU
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MAIA Stock
  4. News MAIA Biotechnology, Inc.
  5. Press Releases